Press release

Siemens Healthineers continues to drive growth forward

Published on July 30, 2019

 

Q3 2019

Q3 2018

Actual change

Revenue

3,569

3,300

8%

Profit

529

503

5%

…Margin

14.8%

15.2%

(40) bps

Adjusted profit

543

528

3%

…Margin

15.2%

16.0%

(80) bps

Net income

353

293

20%

Basic earnings per share in EUR

0.35

0.29

22%

Free cash flow

227

269

(15)%

 

Q3 2019

Q3 2018

Actual change

Imaging

 

 

 

…Total revenue

2,186

1,976

11%

…Profit

407

333

22%

…Profit margin

18.6%

16.8%

180 bps

…Adjusted profit margin

19.1%

17.4%

170 bps

Diagnostics

 

 

 

…Total revenue

1,043

1,007

4%

…Profit

76

105

(28%)

…Profit margin

7.3%

10.4%

(320 bps)

…Adjusted profit margin

7.5%

10.9%

(340 bps)

Advanced Therapies

 

 

 

…Total revenue

378

353

7%

…Profit

65

52

25%

…Profit margin

17.2%

14.8%

240 bps

…Adjusted profit margin

17.3%

17.0%

30 bps

1

2

Siemens Healthineers 2018

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.